Universe Pharmaceuticals INC Income (Loss) from Equity Method Investments
Universe Pharmaceuticals INC (UPC) reported Income (Loss) from Equity Method Investments of $65.06 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-01-29
| Period end | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $65.06M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $31.94M 20-F · filed 2026-01-29 | $31.94K 20-F · filed 2025-04-29 | |
| 2024-03-31 | -$7.62M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $31.07M 20-F · filed 2026-01-29 | $31.07K 20-F · filed 2024-01-30 | |
| 2022-09-30 | $38.59K 20-F · filed 2025-04-29 | ||
| 2021-09-30 | $30.83K 20-F · filed 2024-01-30 | ||
| 2020-09-30 | $21.82K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $26.74K 20-F · filed 2022-01-31 |